Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-25 @ 4:28 AM
NCT ID:
NCT03012620
Brief Title:
Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
Official Title:
Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
Acronym:
AcSé
Study:
NCT03012620
Protocol Section:
NCT03012620